Positive Activities for Asian American Cancer Patients and Caregivers

August 11, 2026 updated by: M.D. Anderson Cancer Center
Positive Activities for Asian American Cancer Patients and Caregivers

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Primary Objectives:

The overall objective of this project is to design and test the feasibility of two positive activities, household contribution and outside contribution, to increase quality of life in AA cancer patients.

Secondary Objectives:

Aim 1: To assess the acceptability and feasibility of household and outside contribution positive activities for AAs through a mixed qualitative and exploratory quantitative investigation.

Aim 2: To use the qualitative and quantitative data from Aim 1, in collaboration with the mentorship team, AA community members, and clinicians, to develop one or both positive activity intervention(s) (i.e., household or outside contribution) specifically for AA cancer patients.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • M D Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion criteria for patients will be:

  • self-identifies as AA,
  • males or females ages 25-75 years
  • within 1 year of any cancer diagnosis
  • actively undergoing systemic therapy (e.g., chemotherapy, radiation)
  • able to identify a caregiver (e.g., spouse) who lives in the same household and consents to participate in the study,
  • able to read, write, and speak English (i.e., English proficient; EP),
  • access to internet, computer/phone, and web browser.

Exclusion criteria for patients will be:

  • life expectancy less than 6 months in the opinion of the primary physician,
  • inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status),
  • major thought disorder (e.g., schizophrenia or bipolar [patient records or

Inclusion criteria for caregivers will be:

  • identifies as AA,
  • patient considers them to be caregiver, -
  • EP,
  • access to computer/phone, internet, and web browser.

Exclusion criteria for caregivers will be:

  • unwilling or unable to participate in the study for any reason,
  • under the age of 18.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Household Contribution
Do something thoughtful or nice for your caregiver that would provide them with tangible support
Behavioral: Household Contribution
Questionnaires
Other: Outside Contribution
Do something outside your home/household that contributes to the larger society
Behavioral: Outside Contribution
Questionnaires
Other: Control
Keep track of your daily activities
Behavioral: Control
Questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Affect-Adjective Scale
Time Frame: End-of-study (4 weeks)
Positive and negative affect were measured using a modified 12-item Affect-Adjective Scale (AAS) (Diener & Emmons, 1984) that included low-arousal emotion items (e.g., peaceful/serene, dull/bored). Participants rated the extent to which they experienced positive and negative emotions over the past week on a scale from 0 ("not at all") to 6 ("extremely").
End-of-study (4 weeks)
Health-Related Quality of Life
Time Frame: End-of-study (4 weeks)
HRQOL was measured using the 10-item Patient-Reported Outcomes Measurement Information System Global-10 (PROMIS-10) (Cella et al., 2010), with physical and mental health subscales. The scale ranges from 5 to 20 with higher scores indicating better health-related quality of life.
End-of-study (4 weeks)
Perceived Stress
Time Frame: End-of-study (4 weeks)
Perceived stress was measured using the 4-item Perceived Stress Scale (PSS) (Cohen & Willliamson, 1988), which assessed the frequency of stressful experiences over the past month. The scale ranges from 0 to 16 with higher scores indicating greater perceived stress.
End-of-study (4 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological Needs
Time Frame: End-of-study (4 weeks)
Psychological needs were measured with a 9-item version of the Balanced Measure of Psychological Needs (BMPN) (Sheldon & Hilpert, 2012), which includes subscales for autonomy, competence, and connectedness. The subscales range from 1 to 5 with higher scores indicating greater satisfaction of the respective need.
End-of-study (4 weeks)
Self-Perceived Burden
Time Frame: End-of-study (4 weeks)
Self-perceived burden was measured using the 10-item Self-Perceived Burden Scale (SPBS) (Cousineau et al., 2003), which assessed the extent to which patients felt that they were a burden on caregivers. The scale ranges from 10 to 50 with higher scores indicating greater self=perceived burden.
End-of-study (4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

M.D. Anderson Cancer Center

Collaborators

National Institutes of Health (NIH)

Investigators

  • Principal Investigator: LI Qian, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2021

Primary Completion (Actual)

November 19, 2024

Study Completion (Actual)

November 19, 2024

Study Registration Dates

First Submitted

November 11, 2021

First Submitted That Met QC Criteria

January 18, 2022

First Posted (Actual)

January 24, 2022

Study Record Updates

Last Update Posted (Actual)

August 13, 2026

Last Update Submitted That Met QC Criteria

August 11, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021-0998
  • NCI-2021-12848 (Other Identifier: NCI-CTRP Clinical Trials Reporting Registry)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe